Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.
Sep 25, 2018
0
121